| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
8,191,588 | 7,401,116 | 6,941,180 | 6,596,950 | 6,150,530 |
|
Cost of Revenue
|
-5,208,140 | -4,733,677 | -4,464,713 | -4,212,485 | -4,005,261 |
|
Gross Profit
|
2,983,448 | 2,667,439 | 2,476,467 | 2,384,465 | 2,145,269 |
|
Selling, General and Administrative Expenses
|
-849,888 | -757,122 | -696,905 | -677,006 | -644,577 |
|
Operating Income/Expenses
|
-849,888 | -757,122 | -696,905 | -677,006 | -644,577 |
|
Total Operating Profit/Loss
|
2,133,560 | 1,910,317 | 1,779,562 | 1,707,459 | 1,500,692 |
| Total Net Finance Income/Expense
|
-113,722 | -81,254 | -112,962 | -81,795 | -83,186 |
|
Other Income/Expense, Non-Operating
|
-38,588 | -30,724 | -5,061 | -19,252 | 11,186 |
|
Non-Operating Income/Expenses, Total
|
-152,310 | -111,978 | -118,023 | -101,047 | -72,000 |
|
Pretax Income
|
1,981,250 | 1,798,339 | 1,661,539 | 1,606,412 | 1,428,692 |
|
Provision for Income Tax
|
-350,096 | -318,197 | -285,415 | -293,224 | -269,150 |
|
Net Income from Continuing Operations
|
1,631,154 | 1,480,142 | 1,376,124 | 1,313,188 | 1,159,542 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
1,631,154 | 1,480,142 | 1,376,124 | 1,313,188 | 1,159,542 |
|
Net Income after Non-Controlling/Minority Interests
|
1,631,154 | 1,480,142 | 1,376,124 | 1,313,188 | 1,159,542 |
|
Net Income Available to Common Stockholders
|
1,631,154 | 1,480,142 | 1,376,124 | 1,313,188 | 1,159,542 |
|
Diluted Net Income Available to Common Stockholders
|
1,631,154 | 1,480,142 | 1,376,124 | 1,313,188 | 1,159,542 |
| Total Gross Dividends
|
-233,530 | -- | -- | -- | -- |
|
Common Dividend per Share
|
1.02 | -- | -- | -- | -- |
| Basic EPS
|
7.12 | 6.42 | 5.95 | 5.70 | 5.04 |
| Diluted EPS
|
7.09 | 6.40 | 5.93 | 5.67 | 5.01 |
|
Basic Weighted Average Shares Outstanding
|
229,183.75 | 230,452 | 231,256 | 230,519 | 230,208 |
|
Diluted Weighted Average Shares Outstanding
|
230,020.75 | 231,259 | 232,168 | 231,509 | 231,536 |
|
Reported Normalized Diluted EPS
|
7.65 | 7.43 | 6.83 | 6.38 | 5.68 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
2,094,972 | 1,879,593 | 1,774,501 | 1,688,207 | 1,511,878 |
|
EBITDA
|
2,527,684 | 2,302,397 | 2,157,428 | 2,025,843 | 1,831,305 |
|
Normalized EBITDA
|
2,577,896 | 2,350,073 | 2,204,296 | 2,071,922 | 1,868,042 |
|
Normalized Income
|
1,672,493.29 | 1,519,379.35 | 1,414,930.70 | 1,350,834.54 | 1,189,372.44 |
|
Total Unusual Items
|
50,212 | 47,676 | 46,868 | 46,079 | 36,737 |
|
Total Unusual Items Excluding Goodwill
|
50,212 | 47,676 | 46,868 | 46,079 | 36,737 |
12/31/2022 - 7/19/1984
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade